Bisphosphonate drugs, meant to treat bone diseases and certain
cancers, may in fact be causing osteonecrosis, or bone death.
While not definitive, there is some evidence that the drugs in IV
form may hinder the growth of new blood vessels.
To continue reading this article, you must login
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.